Search research articles
Contact Us
Filters
Showing results (41-50 of 140) with videos related to
Page
of 14
Sort By:
Cancer
|
October 13, 2001
Interferon-mediated fatigue
U R Malik, D F Makower, S Wadler
Immunopharmacology
|
February 1, 1981
Adjuvant effects of lithium chloride on human mononuclear cells in suppressor-enriched and suppressor-depleted systems
L Shenkman, S Wadler, W Borkowsky, et al.
Cancer
|
February 15, 1996
Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878
S Wadler, B Yeap, S Vogl, et al.
The Journal of Biological Chemistry
|
August 11, 1995
Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil
E L Schwartz, N Baptiste, S Wadler, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks
S Wadler, R Horowitz, X Mao, et al.
Analytical Biochemistry
|
January 27, 1999
Quantification of ribonucleotide reductase expression in wild-type and hydroxyurea-resistant cell lines employing in situ reverse transcriptase polymerase chain reaction and a computerized image analysis system
S Wadler, H Zhang, M Cammer, et al.
The American Journal of Medicine
|
January 1, 1985
Fulminant disseminated carcinomatosis arising from squamous cell carcinoma of the tongue
S Wadler, R Muller, M K Spigelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 1997
Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo
D Makower, S Wadler, H Haynes, et al.
Cancer Research
|
April 1, 1990
Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma
S Wadler, M Goldman, A Lyver, et al.
Biochemical Pharmacology
|
March 17, 1999
Effects of perturbations of pools of deoxyribonucleoside triphosphates on expression of ribonucleotide reductase, a G1/S transition state enzyme, in p53-mutated cells
S Wadler, R Horowitz, H Y Zhang, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 140) with videos related to
Sort By:
Page
of 14
Cancer
|
October 13, 2001
Interferon-mediated fatigue
U R Malik, D F Makower, S Wadler
Immunopharmacology
|
February 1, 1981
Adjuvant effects of lithium chloride on human mononuclear cells in suppressor-enriched and suppressor-depleted systems
L Shenkman, S Wadler, W Borkowsky, et al.
Cancer
|
February 15, 1996
Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878
S Wadler, B Yeap, S Vogl, et al.
The Journal of Biological Chemistry
|
August 11, 1995
Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil
E L Schwartz, N Baptiste, S Wadler, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks
S Wadler, R Horowitz, X Mao, et al.
Analytical Biochemistry
|
January 27, 1999
Quantification of ribonucleotide reductase expression in wild-type and hydroxyurea-resistant cell lines employing in situ reverse transcriptase polymerase chain reaction and a computerized image analysis system
S Wadler, H Zhang, M Cammer, et al.
The American Journal of Medicine
|
January 1, 1985
Fulminant disseminated carcinomatosis arising from squamous cell carcinoma of the tongue
S Wadler, R Muller, M K Spigelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 1997
Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo
D Makower, S Wadler, H Haynes, et al.
Cancer Research
|
April 1, 1990
Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma
S Wadler, M Goldman, A Lyver, et al.
Biochemical Pharmacology
|
March 17, 1999
Effects of perturbations of pools of deoxyribonucleoside triphosphates on expression of ribonucleotide reductase, a G1/S transition state enzyme, in p53-mutated cells
S Wadler, R Horowitz, H Y Zhang, et al.
Page
of 14